Mosquito Defensin C Fights Dengue Virus Through the Ras/ERK Immune Signaling Pathway
The Ras/ERK pathway in Aedes mosquitoes activates defensin C to restrict dengue virus replication, revealing how insect antimicrobial peptides fight viral infections.
Quick Facts
What This Study Found
Ras/ERK signaling activates defensin C in Aedes mosquitoes to restrict DENV infection; ERK knockdown (but not JNK or p38) significantly enhanced viral replication.
Key Numbers
ERK knockdown enhanced DENV replication; Ras/ERK activation decreased viral titers; defensin C restricts DENV
How They Did This
Mosquito cell and midgut studies using RNA interference knockdown (ERK, JNK, p38), pharmacological activation/inhibition of Ras/ERK, viral titer measurement, and AMP expression analysis.
Why This Research Matters
Understanding how mosquitoes naturally fight dengue could lead to strategies for engineering mosquitoes with enhanced viral resistance, reducing dengue transmission to humans.
The Bigger Picture
Dengue infects ~400 million people annually. If mosquitoes can be engineered with enhanced Ras/ERK-defensin C pathways, they could be refractory to dengue, blocking transmission at the vector level.
What This Study Doesn't Tell Us
Mosquito cell and midgut studies — not whole-organism transmission experiments; defensin C may not be the only AMP involved; applicability to other mosquito-borne viruses unknown.
Questions This Raises
- ?Could transgenic mosquitoes overexpressing defensin C block dengue transmission?
- ?Does this Ras/ERK-AMP crosstalk also restrict Zika, chikungunya, or yellow fever viruses?
- ?Can this pathway be pharmacologically boosted in wild mosquito populations?
Trust & Context
- Key Stat:
- ERK-specific antiviral Only ERK (not JNK or p38 MAPK) restricted dengue virus replication via defensin C activation
- Evidence Grade:
- Moderate — multi-approach mechanistic study using genetic and pharmacological methods, but in vitro/ex vivo only.
- Study Age:
- Published in 2020; engineered mosquito vector control strategies are actively being developed.
- Original Title:
- The Ras/ERK signaling pathway couples antimicrobial peptides to mediate resistance to dengue virus in Aedes mosquitoes.
- Published In:
- PLoS neglected tropical diseases, 14(8), e0008660 (2020)
- Authors:
- Liu, Wen-Quan, Chen, Si-Qi, Bai, Hao-Qiang, Wei, Qi-Mei, Zhang, Sheng-Nan, Chen, Chen, Zhu, Yi-Han, Yi, Tang-Wei, Guo, Xiao-Pu, Chen, Si-Yuan, Yin, Meng-Jie, Sun, Chen-Feng, Liang, Shao-Hui
- Database ID:
- RPEP-04961
Evidence Hierarchy
Frequently Asked Questions
How do mosquitoes fight viruses?
Mosquitoes have innate immune systems that produce antimicrobial peptides like defensin C to attack viruses. This study shows the Ras/ERK signaling pathway controls this defense against dengue.
Could this help prevent dengue in people?
Not directly, but if researchers can engineer mosquitoes with stronger defensin C responses, those mosquitoes couldn't carry dengue — preventing transmission to humans.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-04961APA
Liu, Wen-Quan; Chen, Si-Qi; Bai, Hao-Qiang; Wei, Qi-Mei; Zhang, Sheng-Nan; Chen, Chen; Zhu, Yi-Han; Yi, Tang-Wei; Guo, Xiao-Pu; Chen, Si-Yuan; Yin, Meng-Jie; Sun, Chen-Feng; Liang, Shao-Hui. (2020). The Ras/ERK signaling pathway couples antimicrobial peptides to mediate resistance to dengue virus in Aedes mosquitoes.. PLoS neglected tropical diseases, 14(8), e0008660. https://doi.org/10.1371/journal.pntd.0008660
MLA
Liu, Wen-Quan, et al. "The Ras/ERK signaling pathway couples antimicrobial peptides to mediate resistance to dengue virus in Aedes mosquitoes.." PLoS neglected tropical diseases, 2020. https://doi.org/10.1371/journal.pntd.0008660
RethinkPeptides
RethinkPeptides Research Database. "The Ras/ERK signaling pathway couples antimicrobial peptides..." RPEP-04961. Retrieved from https://rethinkpeptides.com/research/liu-2020-the-raserk-signaling-pathway
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.